Lilly Pens Angry Response To New York Times Article
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly slams the Times for “implications” the firm suppressed negative clinical trial results for Prozac and Cymbalta in newspaper's report on NEJM publication biases study.